Elara sees the ongoing weakness as an opportunity to buy into the pharma space, as it expects robust earnings growth ahead at ...

Aurobindo Pharma’s Q3 net profit declined 10% YoY to Rs 846 crore, despite record revenue of Rs 7,979 crore. US sales ...

Pharma stocks tumbled as the Nifty Pharma index dropped two percent, with Alkem, Ipca, and Divi’s Labs leading losses.

Aurobindo Pharma Ltd share price was up by 0.00% from the previous closing price of ₹1,191.75. Who are peers of Aurobindo Pharma Ltd? The peers of Aurobindo Pharma Ltd are Sun Pharmaceuticals ...

Aurobindo Pharma’s revenue beat our estimates (+2.8%) due to strong performance in Europe and Growth markets. EBITDA beat our estimates (+4.4%) due to better than expected gross profit and Adj.

Generic drugmaker Aurobindo Pharma has received order under the Central Goods and Services Tax Act, 2017, asking it to pay GST, interest and a penalty of more than ₹155 crore. Additional ...

Hyderabad: Degrowth in its US formulations business dragged down Aurobindo Pharma's consolidated net profits for the third quarter ended December 31, 2024, by 10% to 846 crore from 940 crore ...

Indian drugmaker Aurobindo Pharma reported a lower third-quarter profit on Thursday, as a spike in expenses more than offset strong demand for its generic drugs. The company's consolidated net profit ...